[
    [
        {
            "time": "2020-08-06",
            "original_text": "疫苗股集体暴跌背后：多股一个月内股价翻倍，半年报业绩平平",
            "features": {
                "keywords": [
                    "疫苗股",
                    "暴跌",
                    "股价翻倍",
                    "半年报",
                    "业绩平平"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "疫苗股集体暴跌背后：多股一个月内股价翻倍，半年报业绩平平",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-08-06",
            "original_text": "康泰生物获阿斯利康新冠疫苗独家授权 疫苗研发需警惕概念化炒作",
            "features": {
                "keywords": [
                    "康泰生物",
                    "阿斯利康",
                    "新冠疫苗",
                    "独家授权",
                    "概念化炒作"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康泰生物获阿斯利康新冠疫苗独家授权 疫苗研发需警惕概念化炒作",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-08-06",
            "original_text": "美国三大股指小幅低开，西部数据大跌逾12%",
            "features": {
                "keywords": [
                    "美国",
                    "三大股指",
                    "低开",
                    "西部数据",
                    "大跌"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技",
                    "金融"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "美国三大股指小幅低开，西部数据大跌逾12%",
                "Correlation": 3,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-08-06",
            "original_text": "康泰生物：将获阿斯利康腺病毒载体新冠疫苗独家授权",
            "features": {
                "keywords": [
                    "康泰生物",
                    "阿斯利康",
                    "腺病毒载体",
                    "新冠疫苗",
                    "独家授权"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康泰生物：将获阿斯利康腺病毒载体新冠疫苗独家授权",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-08-06",
            "original_text": "药闻速递 | 中纪委发文：彻查医药腐败；GSK全球首个BCMA抗体偶联药物获FDA加速批准",
            "features": {
                "keywords": [
                    "中纪委",
                    "医药腐败",
                    "GSK",
                    "BCMA",
                    "抗体偶联药物",
                    "FDA",
                    "批准"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药闻速递 | 中纪委发文：彻查医药腐败；GSK全球首个BCMA抗体偶联药物获FDA加速批准",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-08-06",
            "original_text": "康泰生物今日跌停，机构卖出为主",
            "features": {
                "keywords": [
                    "康泰生物",
                    "跌停",
                    "机构卖出"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康泰生物今日跌停，机构卖出为主",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-08-06",
            "original_text": "高价股现分歧，普涨行情能否持续？",
            "features": {
                "keywords": [
                    "高价股",
                    "分歧",
                    "普涨行情",
                    "持续"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高价股现分歧，普涨行情能否持续？",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-08-06",
            "original_text": "阿斯利康与康泰生物签新冠疫苗独家授权：年产能至少1亿剂",
            "features": {
                "keywords": [
                    "阿斯利康",
                    "康泰生物",
                    "新冠疫苗",
                    "独家授权",
                    "年产能",
                    "1亿剂"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "阿斯利康与康泰生物签新冠疫苗独家授权：年产能至少1亿剂",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-08-06",
            "original_text": "搜狐医药 | 阿斯利康签署新冠疫苗中国内地市场独家授权！将实现两亿剂年产能",
            "features": {
                "keywords": [
                    "搜狐医药",
                    "阿斯利康",
                    "新冠疫苗",
                    "中国内地",
                    "独家授权",
                    "两亿剂",
                    "年产能"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "搜狐医药 | 阿斯利康签署新冠疫苗中国内地市场独家授权！将实现两亿剂年产能",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-08-06",
            "original_text": "A股收盘综述：上证指数探底回升，券商股尾盘急拉",
            "features": {
                "keywords": [
                    "A股",
                    "上证指数",
                    "探底回升",
                    "券商股",
                    "尾盘急拉"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股收盘综述：上证指数探底回升，券商股尾盘急拉",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-08-06",
            "original_text": "疫苗概念股下挫，康华生物跌停",
            "features": {
                "keywords": [
                    "疫苗概念股",
                    "下挫",
                    "康华生物",
                    "跌停"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "疫苗概念股下挫，康华生物跌停",
                "Correlation": 8,
                "Sentiment": 2,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]